Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy
- PMID: 40141708
- PMCID: PMC11943963
- DOI: 10.3390/life15030363
Non-Alcoholic Fatty Liver Disease in Everyday Clinical Practice: From Diagnosis to Therapy
Abstract
Non-alcoholic fatty liver disease (NAFLD) is currently one of the most common hepatic disorders observed in daily medical practice [...].
Conflict of interest statement
The authors declare no conflicts of interest.
References
-
- Lazarus J.V., Mark H.E., Anstee Q.M., Arab J.P., Batterham R.L., Castera L., Cortez-Pinto H., Crespo J., Cusi K., Dirac M.A., et al. NAFLD Consensus Consortium. Advancing the global public health agenda for NAFLD: A consensus statement. Nat. Rev. Gastroenterol. Hepatol. 2022;19:60–78. doi: 10.1038/s41575-021-00523-4. - DOI - PubMed
-
- Amini-Salehi E., Letafatkar N., Norouzi N., Joukar F., Habibi A., Javid M., Sattari N., Khorasani M., Farahmand A., Tavakoli S., et al. Global Prevalence of Nonalcoholic Fatty Liver Disease: An Updated Review Meta-Analysis comprising a Population of 78 million from 38 Countries. Arch. Med. Res. 2024;55:103043. doi: 10.1016/j.arcmed.2024.103043. - DOI - PubMed
-
- Kounatidis D., Vallianou N.G., Geladari E., Panoilia M.P., Daskou A., Stratigou T., Karampela T., Tsilingiris D., Dalamaga M. NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics. Biomedicines. 2024;12:826. doi: 10.3390/biomedicines12040826. - DOI - PMC - PubMed
-
- Xiao J., Han Ng C., Chan K.E., Fu C., Tay P., Yong J.N., Lim W.H., Tan D.J.H., Syn N., Wong Z.Y., et al. Hepatic, Extra-hepatic Outcomes and Causes of Mortality in NAFLD—An Umbrella Overview of Systematic Review of Meta-Analysis. J. Clin. Exp. Hepatol. 2023;13:656–665. doi: 10.1016/j.jceh.2022.11.006. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
